Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)
Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%
Lifevantage net income
Net income is the profit left for shareholders after every expense, interest and tax.
Lifevantage's net income for the twelve months ending Jun 30, 2026 was $5.07M, down 48.3% year over year. For fiscal 2026 it was $5.07M, down 48.3% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is $12.89M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $5.07M | -48.3% |
| FY2025 | Jun 30, 2025 | $9.81M | +233.8% |
| FY2024 | Jun 30, 2024 | $2.94M | +15.6% |
| FY2023 | Jun 30, 2023 | $2.54M | -18.6% |
| FY2022 | Jun 30, 2022 | $3.12M | -75.8% |
| FY2021 | Jun 30, 2021 | $12.89M | +11.6% |
| FY2020 | Jun 30, 2020 | $11.55M | +55.5% |
| FY2019 | Jun 30, 2019 | $7.43M | +29.0% |
| FY2018 | Jun 30, 2018 | $5.76M | +258.3% |
| FY2017 | Jun 30, 2017 | $1.61M | -73.7% |
| FY2016 | Jun 30, 2016 | $6.11M | -14.3% |
| FY2015 | Jun 30, 2015 | $7.13M | -37.4% |
| FY2014 | Jun 30, 2014 | $11.38M | +49.6% |
| FY2013 | Jun 30, 2013 | $7.61M | -39.0% |
| FY2012 | Jun 30, 2012 | $12.47M | – |
| FY2011 | Jun 30, 2011 | -$50.79M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.28M | -34.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.36M | -60.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $276.00K | -89.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.16M | +18.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.96M | +50.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.47M | +109.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.55M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $1.83M | +190.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.31M | -33.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $1.66M | +62.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$656.00K | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $629.00K | +3.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.97M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.02M | -10.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$1.06M | -1439.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $610.00K | -81.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$1.42M | -128.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.14M | -33.8% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $79.00K | -97.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $3.32M | +35.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $4.91M | +28.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.72M | +3.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $3.81M | -11.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $2.45M | +39.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.82M | -2.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.66M | -6.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $4.30M | +419.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.76M | +93.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $3.91M | +30.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.78M | +9.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $829.00K | +161.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $911.00K | +11.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $2.99M | +3461.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $1.64M | +2580.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $317.00K | +12.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $817.00K | -30.8% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $84.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $61.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $283.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $1.18M | – |
See a number that looks wrong?